Half-yearly Report
Keydata AIM VCT
KEYDATA AIM VCT plc
Unaudited Interim Results for the six
months ending 31 March 2009
Chairman’s Statement
During the six month period, the fund’s NAV declined by 12.5% against a backdrop of a 33.6% fall in the FTSE AIM All Share index. While it is always distressing to report a loss, this is a creditable performance under the circumstances.
Conversion of C shares
On 7 October 2008, in accordance with the Articles of Association, the C shares were converted into new Ordinary shares based on the respective net asset value per share of each fund at 30 September 2008. The conversion ratio was 1.23935 new ordinary shares for each C share held on 7 October 2008. The 17,719,270 C shares in issue were converted into 21,959,891 new ordinary shares which rank pari passu with the existing ordinary shares. The two investment funds were combined from this date
Results - Ordinary Fund
The net asset value per ordinary share decreased by 12.5% to 57.91 pence during the period. In the same period, the FTSE AIM All Share index fell 33.6%. Adjusted for dividends paid, the total return is 72.91 pence, a 9.1% reduction in the period. The loss per ordinary share for the period was 7.22 pence per share (comprising revenue profit of 0.06 pence and capital loss of 7.28 pence).
As at 31 March 2009, 69% of the fund was invested in equities and 31% in gilts and corporate bonds.
The Investment Manager invested a further £0.3 million in one qualifying AIM company during the period and made full or part disposals of 4 of the AIM investments, realising a net loss on sale of £0.8 million in the period. The main contributors to this realised loss were Zenith Hygiene, Optimisa and Work Group. In addition, 4 qualifying investments went into administration during the period (Fishworks, EBTM, Business Direct Group and Vicorp) realising a combined loss of £1.1 million. The bid value of qualifying investments at 31 March 2009 was £8.95 million invested in 52 AIM companies. With respect to the 70% investment test, as at 31 March 2009, 71.8% of the Company’s investments were in VCT Qualifying companies.
During the period, 10,000 ordinary shares were bought back for cancellation at a total cost of £84,800.
Results of an extraordinary general meeting held on 19 May 2009
Shareholders resolved at an EGM held on 19 May 2009 to pass all resolutions proposed in a circular dated 9 April 2009.
Tender Offer
At the EGM, a special resolution was passed by shareholders to give approval for a tender offer of up to 8,000,000 ordinary shares at a price of 52 pence per share. Valid acceptances were received by the closing date of 30 April 2009 from 179 shareholders for 5,076,447 ordinary shares which will be repurchased either for cancellation (2,365,313 shares) or for holding in treasury for issue by the company at a future date (2,711,134 shares). Cheques will be posted to shareholders by 29 May 2009.
Amendment to Investment Policy
At the EGM, an ordinary resolution was passed by shareholders to amend the investment policy of the fund to permit targeted investments in equities which are non-qualifying investments on an opportunistic basis to boost the performance of the fund. This strategy has been successfully deployed by Keydata AIM VCT 2 plc over the last 2 years.
Dividend
We are delighted to declare an interim dividend payable to ordinary shareholders of 2 pence per share (2008 – 4 pence). This interim dividend will be payable on 30 June 2009 to ordinary shareholders on the share register on 12 June 2009.
Outlook
The FTSE AIM index has recovered by 16% in April 2009. In comparison, the NAV on the Ordinary share fund increased by 6.6% to 61.72 pence per share at 30 April 2009.
While some commentators have reported signs of green shoots on the back of the money that the Treasury has pumped into the economy, we remain cautious in the medium term.
However with share prices at rock bottom there should be some attractive opportunities to invest in sound companies that merit capital for sensible expansion plans. While markets have been largely closed for new investment over much of the last year, we are seeing more activity in the last few weeks on the back of the rebound in equity markets.
Shareholder Communication
The Company’s daily share price can be found on various financial websites under the EPIC code “KEY†for ordinary shares or on our own dedicated website at www.keydata.co.uk/aimvct
Sir Aubrey Brocklebank Bt
Chairman
20 May 2009
Income Statement for the six months ended 31 March 2009 (unaudited)
 | For the six months to | |||||
31 March 2009(unaudited) | ||||||
Revenue | Â | Capital | Â | Total | ||
£000 | £000 | £000 | ||||
Realised gains on investments | (1,595) | (1,595) | ||||
Unrealised losses on investments | - | (691) | (691) | |||
Income |
216 Â |
- Â |
216 Â |
|||
216 | (2,286) | (2,070) | ||||
 | ||||||
Management fee | (21) | (62) | (83) | |||
Other expenses |
(177) Â |
- Â |
(177) Â |
|||
(198) | (62) | (260) | ||||
 |
 |
 |
||||
Loss before taxation | 18 | (2,348) | (2,330) | |||
Taxation | - | - | - | |||
 |
 |
 |
||||
Loss after taxation |
18 Â |
(2,348) Â |
(2,330) Â |
|||
Loss per share (Note 2) | 0.06p | (7.28)p | (7.22)p | |||
 | ||||||
The total column of this statement is the income statement of the
Company. All |
||||||
 |
Income Statement for the six months ended 31 March 2008 (unaudited)
 | For the six months to | |||||
31 March 2008 (unaudited) | ||||||
Revenue | Â | Capital | Â | Total | ||
£000 | £000 | £000 | ||||
Realised gains on investments | 565 | 565 | ||||
Unrealised losses on investments | - | (4,034) | (4,034) | |||
Income |
351 Â |
- Â |
351 Â |
|||
351 | (3,469) | (3,118) | ||||
 | ||||||
Management fee | (39) | (115) | (154) | |||
Other expenses |
(217) Â |
- Â |
(217) Â |
|||
(256) | (115) | (371) | ||||
 |
 |
 |
||||
Profit (loss) before taxation | 95 | (3,584) | (3,489) | |||
Taxation | - | - | - | |||
 |
 |
  |
||||
Profit (loss) after taxation |
95 Â |
(3,584) Â |
(3,489) Â |
|||
 | ||||||
The total column of this statement is the income statement of the
Company. All |
||||||
 |
Income Statement for the year ended 30 September 2008
 | For the year ended | |||||
30 September 2008 (unaudited) | ||||||
Revenue | Â | Capital | Â | Total | ||
£000 | £000 | £000 | ||||
Realised gains on investments | - | 688 | 688 | |||
Unrealised gains on investments | - | (7,508) | (7,508) | |||
Income |
661 Â |
- Â |
661 Â |
|||
661 | (6,820) | (6,159) | ||||
 | ||||||
Management fee | (68) | (204) | (272) | |||
Other expenses |
(288) Â |
- Â |
(288) Â |
|||
(356) |
(204) | (560) | ||||
 |
 |
 |
||||
Profit before taxation | 305 | (7,024) | (6,719) | |||
Taxation | (38) | 38 | - | |||
 |
 |
 |
||||
Profit after taxation |
267 Â |
(6,986) Â |
(6,719) Â |
|||
 | ||||||
The total column of this statement is the profit and loss account
of the Company. |
||||||
 |
Balance sheet as at 31 March 2009 (unaudited)
 |  | 31 March 2009 |  |  | 30 Sep 2008 |  |  | 31 March 2008 | |
£000 | £000 | £000 | |||||||
Fixed assets | |||||||||
Investments |
13,033 Â |
20,694 Â |
20,490 Â |
||||||
Current assets | |||||||||
Prepayments and accrued income | 44 | 156 | 34 | ||||||
Cash at bank and on deposit |
5,635 Â |
609 Â |
6,462 Â |
||||||
5,679 | 765 | 6,496 | |||||||
Creditors: amounts falling due within one year | |||||||||
Accruals and deferred income |
(71) Â |
(81) Â |
(94) Â |
||||||
Net current assets |
5,608 Â |
684 Â |
6,402 Â |
||||||
Net assets |
18,641 Â |
21,378 Â |
26,892 Â |
||||||
Capital and Reserves | |||||||||
Called up share capital | 322 | 989 | 1,019 | ||||||
Capital redemption reserve | 718 | 51 | 20 | ||||||
Capital reserve – realised | (1,939) | 40 | 424 | ||||||
Capital reserve – unrealised | (6,351) | (5,660) | (2,187) | ||||||
Special reserve | 25,614 | 25,699 | 27,405 | ||||||
Revenue reserve |
277 Â |
259 Â |
211 Â |
||||||
Equity shareholders’ funds |
18,641 Â |
21,378 Â |
26,892 Â |
||||||
Net asset value per share (Note 4) | 57.91p | 66.21p | 88.52p | ||||||
 |
Cash flow statement for the six months ended 31 March 2009 (unaudited)
 |  | 6 months to |  |  | 12 months to |  |  | 6 months to | |
31 March 2009 | 30 Sep 2008 | 31 March 2008 | |||||||
£000 | £000 | £000 | |||||||
Profit (loss) before taxation | 18 | 305 | 95 | ||||||
Management fee charged to capital | (62) | (204) | (115) | ||||||
Decrease (increase) in debtors | 112 | (107) | 15 | ||||||
(Decrease) increase in creditors | (10) |
(35) |
(21) | ||||||
 |
 |
 |
|||||||
Net cash inflow (outflow) from operating | |||||||||
activities | |||||||||
 | |||||||||
Financial investment: | 58 | (41) | (26) | ||||||
Purchase of investments | (7,592) | (7,757) | (950) | ||||||
Sale of investments
Net financial investment |
12,967
5,375 |
11,786
4,029 |
8,532
7,582 |
||||||
Dividends paid | |||||||||
 | |||||||||
Cash flow before management of liquid | |||||||||
resources | (322) | (712) | (134) | ||||||
 | |||||||||
Financing: | 5,111 | 3,276 | 7,422 | ||||||
Purchase and cancellation of share capital |
(85) Â |
(3,395) Â |
(1,688) Â |
||||||
Increase (decrease) in cash |
5,026 Â |
(119) Â |
5,734 Â |
||||||
 |
Reconciliation of movements in shareholders’ funds for the six months to 31 March 2009 (unaudited)
Ordinary Shares | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | ||||||
Share | Capital | Capital | Capital | Special | Revenue | |||||||||||||
Capital | Redemption | Reserve | Reserve | Reserve | Reserve | |||||||||||||
Reserve | Realised | Unrealised | ||||||||||||||||
£000 | £000 | £000 | £000 | £000 | £000 | |||||||||||||
 | ||||||||||||||||||
At 1 October 2008 | 989 | 51 | 40 | (5,660) | 25,699 | 259 | ||||||||||||
Conversion of C shares |
(666) |
666 |
- |
- |
- |
- |
||||||||||||
Previously recognised gains now realised |
- |
- |
(1,595) |
1,838 |
- |
- |
||||||||||||
 |
 |
 |
 |
 |
 |
|||||||||||||
Unrealised loss on |
- |
- | - | (2,529) | - | - | ||||||||||||
Management fee charged |
- | - | (62) | - | - | - | ||||||||||||
Cancellation of shares | (1) | 1 | - | - | (85) | - | ||||||||||||
Equity dividends paid | - | - | ` (322) | - | - | - | ||||||||||||
Profit after taxation for the |
- Â |
- Â |
- Â |
- Â |
- Â |
18 Â |
||||||||||||
At 31 March 2009 |
322 Â |
718 Â |
(1,939) Â |
(6,351) Â |
25,614 Â |
277 Â |
||||||||||||
 |
Reconciliation of movements in shareholders’ funds for the six months to 31 March 2008 (unaudited)
Ordinary Shares | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||||||
Share | Capital | Capital | Capital | Special | Revenue | ||||||||||||||
Capital | Redemption | Reserve | Reserve | Reserve | Reserve | ||||||||||||||
Reserve | Realised | Unrealised | |||||||||||||||||
£000 | £000 | £000 | £000 | £000 | £000 | ||||||||||||||
At 1 October 2007 | 143 | - | 128 | 1,593 | 12,999 | 116 | |||||||||||||
Previously recognised gains now |
- | - | 333 | (333) | - | - | |||||||||||||
Unrealised loss on investments | - | - | - | (2,289) | - | - | |||||||||||||
Management fee charged to capital | - | - | (50) | - | - | - | |||||||||||||
Cancellation of shares | (18) | 18 | -` | - | (1,521) | - | |||||||||||||
Profit after taxation for the |
- Â |
- Â |
- Â |
- Â |
- Â |
(19) Â |
|||||||||||||
At 31 March 2008 |
125 Â |
18 Â |
411 Â |
(1,029) Â |
11,478 Â |
97 Â |
C Shares | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||||||
Share | Capital | Capital | Capital | Special | Revenue | |||||||||||
Capital | Redemption | Reserve | Reserve | Reserve | Reserve | |||||||||||
Reserve | Realised | Unrealised | ||||||||||||||
£000 | £000 | £000 | £000 | £000 | £000 | |||||||||||
At 1 October 2007 | 896 | - | (154) | 254 | 16,094 | 134 | ||||||||||
Previously recognised gains |
- | - | 232 | (232) | - | - | ||||||||||
Unrealised loss on |
- | - | - | (1,180) | - | - | ||||||||||
Management fee charged to capital | - | - | (65) | - | - | - | ||||||||||
Cancellation of shares
Equity dividends paid |
(2)
- |
2
- |
-
- |
-
- |
(167)
- |
-
(134) |
||||||||||
Profit after taxation for the |
- Â |
- Â |
- Â |
- Â |
- Â |
114 Â |
||||||||||
At 31 March 2008 |
894 Â |
2 Â |
13 Â |
(1,158) Â |
15,927 Â |
114 Â |
||||||||||
 |
Notes to the interim report
1 | Â | Â | Â | The accounts of the company are prepared in accordance with Accounting Standards applicable in the United Kingdom. The accounting policies used in preparing this report are consistent with those adopted at the year end. All AIM investments are valued at bid price. |
2 | The loss per ordinary share of 7.22p is based on the loss after tax for the period of £2,285,803 and the weighted average number of ordinary shares in issue over the six month period of 32,204,463. | |||
3 | The results should not be taken as a guide to the results for the year ending 30 September 2009 | |||
4 | The net asset value per ordinary share at 31 March 2009 of 57.91p is based on net assets of £18,641,284 and on 32,187,796 shares, being the number of ordinary shares in issue as at 31 March 2009. | |||
5 | The financial information contained in the 31 March 2009 income statement, balance sheet, cash flow statement and reconciliation of movements in shareholders’ funds does not constitute full financial statements and has not been audited. |
Investment portfolio summary as at 31 March 2009
Qualifying investments | Â | Â |
Book cost  |
 |  |
Valuation  |
 |  |
Valuation  |
Cohort | 802 | 979 | 7.5 | ||||||
Abcam | 209 | 750 | 5.8 | ||||||
Intercede | 518 | 643 | 4.9 | ||||||
CBG | 534 | 499 | 3.8 | ||||||
Advanced Computer Software | 400 | 471 | 3.6 | ||||||
Brulines | 540 | 404 | 3.1 | ||||||
Relax | 650 | 389 | 3.0 | ||||||
Pressure Technologies | 340 | 385 | 3.0 | ||||||
Mount Engineering | 400 | 377 | 2.9 | ||||||
Animalcare | 300 | 371 | 2.8 | ||||||
FDM | 250 | 314 | 2.4 | ||||||
Mama | 300 | 276 | 2.1 | ||||||
Craneware | 150 | 255 | 2.0 | ||||||
Keycom | 300 | 225 | 1.7 | ||||||
Rotala | 400 | 205 | 1.6 | ||||||
Optare | 548 | 198 | 1.5 | ||||||
Idox | 150 | 185 | 1.4 | ||||||
Vertu Motors | 600 | 180 | 1.4 | ||||||
K3 Business Technology | 270 | 174 | 1.3 | ||||||
Feedback | 201 | 117 | 0.9 | ||||||
Jelf | 174 | 103 | 0.8 | ||||||
Universe | 385 | 96 | 0.7 | ||||||
Plastics Capital | 250 | 93 | 0.7 | ||||||
Neutrahealth | 315 | 90 | 0.7 | ||||||
Sectorguard | 250 | 89 | 0.7 | ||||||
Energetix | 380 | 86 | 0.7 | ||||||
Portland Gas | 46 | 83 | 0.6 | ||||||
Innovision Research | 175 | 78 | 0.6 | ||||||
Infoserve Group | 200 | 76 | 0.6 | ||||||
Advanced Power Components | 148 | 74 | 0.6 | ||||||
Hexagon Human Capital | 300 | 69 | 0.5 | ||||||
Maxima | 251 | 65 | 0.5 | ||||||
Tangent Communications | 300 | 63 | 0.5 | ||||||
Invocas | 169 | 58 | 0.4 | ||||||
Tasty | 288 | 57 | 0.4 | ||||||
Autoclenz | 256 | 47 | 0.4 | ||||||
Richoux | 300 | 42 | 0.3 | ||||||
Essentially Group | 220 | 39 | 0.3 | ||||||
St Helens Capital | 211 | 37 | 0.3 | ||||||
Enfis | 146 | 36 | 0.3 | ||||||
Reneuron | 168 | 22 | 0.2 | ||||||
Alterian | 145 | 22 | 0.2 | ||||||
Egdon Resources | 8 | 21 | 0.2 | ||||||
Expansys | 389 | 20 | 0.2 | ||||||
Invu | 200 | 18 | 0.1 | ||||||
TMN Group | 173 | 17 | 0.1 | ||||||
Axeon | 200 | 13 | 0.1 | ||||||
Sports Media Group | 300 | 12 | 0.1 | ||||||
Hardide | 396 | 11 | 0.1 | ||||||
York Pharma | 250 | 6 | 0.0 | ||||||
Centrom | 400 | 3 | 0.0 | ||||||
Accuma |
50 Â |
3 Â |
0.0 Â |
||||||
Total qualifying investments |
15,305 Â |
8,946 Â |
68.6 Â |
||||||
Non-qualifying investments |
 |
||||||||
 | |||||||||
Treasury 2.25% Stock 2014 | 981 | 987 | 7.6 | ||||||
Treasury 2.5% Indexed Linked 2016 | 491 | 491 | 3.8 | ||||||
Treasury 2.5% Indexed Linked 2020 | 482 | 486 | 3.7 | ||||||
 |
 |
 |
|||||||
Total – UK Gilts | 1,954 | 1,964 | 15.1 | ||||||
 |
 |
 |
|||||||
 | |||||||||
Lloyds TSB 4% 2011 | 1,024 | 1,039 | 8.0 | ||||||
Nationwide BS 3.75% 2011 | 1,018 | 1,034 | 7.9 | ||||||
 |
 |
 |
|||||||
Total – UK Corporate bonds | 2,042 | 2,073 | 15.9 | ||||||
 |
 |
 |
|||||||
Non-qualifying AIM investments | 83 | 50 | 0.4 | ||||||
 |
 |
 |
|||||||
Total non-qualifying investments |
4,079 Â |
4,087 Â |
31.4 Â |
||||||
Total investments |
19,384 Â |
13,033 Â |
100.0 Â |
||||||
 |
Top ten investments at 31 March 2009 by valuation
1. Cohort plc | Â | Â | Â | 159p | ||
Investment date | Â | February 2006 | Â | Unaudited results for 6 mths to | October 08 | |
Equity held | 1.52% | Turnover (£’000) | 33,900 | |||
Purchase Price | 123p | Profit before tax (£’000) | 2,600 | |||
Cost (£’000) | 802 | Net Assets (£’000) | 42,529 | |||
Valuation (£’000) | 979 | |||||
 | ||||||
Cohort is an independent technology business operating in defense and related markets. It was formed in 2006 as a holding company to acquire and grow businesses capitalizing on the growing demand in the UK and overseas, for independent technical advice and cost effective and flexible supply of niche products and services. It now has three well established, wholly owned subsidiaries providing a wide range of services and products covering the full defense procurement cycle in land, sea and air systems. | ||||||
 |
2. Abcam plc | Â | Â | Â | 600p | ||
Investment date | Â | October 2005 | Â | Unaudited results for 6 months to | December 08 | |
Equity held | 0.36% | Turnover (£’000) | 23,074 | |||
Purchase Price | 167p | Profit before tax (£’000) | 6,820 | |||
Cost (£’000) | 209 | Net assets (£’000) | 28,561 | |||
Valuation (£’000) | 750 | |||||
 | ||||||
Abcam is a producer and distributor of research-grade antibodies headquartered in Cambridge, UK, with offices in Cambridge, Massachusetts, USA and Tokyo, Japan. The Company produces and distributes its own and third party produced antibodies to academic and commercial users throughout the world. Product ordering is available through the Company's website where customers are also able to access up-to-date and detailed technical product data sheets. All the antibodies are sold under the Abcam brand name and the Company's vision is to build the world's largest online resource of high quality and commercially viable antibodies. | ||||||
 |
3. Intercede plc | Â | Â | Â | 41p | ||
Investment date | Â | May 2007 | Â | Unaudited results for 6 months to | September 08 | |
Equity held | 4.20% | Turnover (£’000) | 1,981 | |||
Purchase Price | 33p | Profit before tax (£’000) | 222 | |||
Cost (£’000) | 518 | Net assets (£’000) | (815) | |||
Valuation (£’000) | 643 | |||||
 | ||||||
Intercede Group plc is a leading developer and supplier of smart card and identity credential management software. The company’s principal product, MyID, is a software solution that manages the secure registration, issuance and lifecycle of identity credentials and devices. | ||||||
 |
4. CBG plc | Â | Â | Â | 105p | ||
Investment date | Â | Nov 06 | Â | Unaudited results for 6 mths to | December 08 | |
Equity held | 3.08% | Turnover (£’000) | 11,148 | |||
Purchase Price | 102p | Profit before tax (£’000) | 1,093 | |||
Cost (£’000) | 534 | Net assets (£’000) | 12,278 | |||
Valuation (£’000) | 499 | |||||
 | ||||||
CBG Group is a Manchester based corporate general insurance, risk management and financial services intermediary. The Group offers a range of services principally in the area of commercial insurance, business risk management, healthcare and employee benefits. It also offers private client solutions to individuals centered on wealth management asset protection. | ||||||
 |
5. Advanced Computer Software plc | Â | Â | Â | 20p | ||
Investment date | Â | July 08 | Â | Unaudited results for 6 months to | February 09 | |
Equity held | 1.23% | Turnover (£’000) | 7,327 | |||
Purchase Price | 17p | Profit before tax (£’000) | 1,459 | |||
Cost (£’000) | 400 | Net assets (£’000) | 25,442 | |||
Valuation (£’000) | 471 | |||||
 | ||||||
Under new management, Advanced Computer Software plc (formerly known as Drury Lane) raised £14.6m in July 2008 to acquire Adastra Software Ltd, a data distribution and clinical support software provider to the primary care sectors in the UK, Ireland and the Netherlands as the first step to becoming a leading provider of software and services to the UK primary care market (the provision of first line patient services such as GPs, walk-in-centers, district nursing, and out-of-hours services). The Company's strategy is to consolidate the fragmented healthcare software market, through selective acquisitions, with a focus on primary care. | ||||||
 |
6. Brulines plc | Â | Â | Â | Â | Â | 92p |
Investment date | October 06 | Â | Unaudited results for 6 mths to | Sept 08 | ||
Equity held | 1.57% | Turnover (£’000) | 8,896 | |||
Purchase Price | 123p | Profit before tax (£’000) | 2,165 | |||
Cost (£’000) | 541 | Net assets (£’000) | 13,943 | |||
Valuation (£’000) | 405 | |||||
 | ||||||
Brulines is a leading provider of volume and revenue protection systems for draught alcoholic drinks for the UK Licensed on-trade, in particular the tenanted pub sector. The Dispense Monitoring Division, which represents the Group’s core product, measures the actual volume of liquid dispensed each hour against legitimate deliveries and protects the pub owners from the potential loss of revenue from ‘buying out’. The Group also has a Brand Quality Monitoring solution undergoing commercial trials with a number of customers. In September 2008 they acquired Edensure Ltd, which provides Intelligent Forecourt Solutions for the UK Petrol forecourt market, and in December 2008 it completed the acquisition of Vianet Ltd, that provides market leading telemetry and data capture solutions to the vending industry. | ||||||
 |
7. Relax plc | Â | Â | Â | 56p | ||
Investment date | Â | May 2006 | Â | Audited results for year to | July 2008 | |
Equity held | 2.28% | Turnover (£’000) | 12,923 | |||
Purchase Price | 180p | Profit before tax (£’000) | 14 | |||
Cost (£’000) | 650 | Net Assets (£’000) | 13,581 | |||
Valuation (£’000) | 389 | |||||
 | ||||||
Relax plc, formerly known as Debts.co.uk, provides a range of solutions to over-indebted individuals that includes IVAs, trust deeds, debt management programs, bankruptcy and secured loans. | ||||||
 |
8. Pressure Technologies plc | Â | Â | Â | 170p | ||
Investment date | Â | May 2007 | Â | Audited results for year to | September 08 | |
Equity held | 2.00% | Turnover (£’000) | 23,660 | |||
Purchase Price | 150p | Profit before tax (£’000) | 5,046 | |||
Cost (£’000) | 340 | Net assets (£’000) | 11,167 | |||
Valuation (£’000) | 385 | |||||
 | ||||||
Pressure Technologies plc designs, manufactures and offers testing and refurbishment services for a range of specialty high pressure, seamless steel gas cylinders for global energy, defense and industrial gases markets. The business is conducted under the 'Chesterfield' brand which is a long established name in the cylinders and specialized pressure vessel market. The company is aiming to grow the business through a mixture of organic growth, diversification and acquisition of complementary business to achieve a GBP 40 million turnover business within five years. | ||||||
 |
9. Mount Engineering plc | Â | Â | Â | 66p | ||
Investment date | Â | June 2007 | Â | Unaudited results for year to | December 2008 | |
Equity held | 2.35% | Turnover (£’000) | 11,778 | |||
Purchase Price | 70p | Profit before tax (£’000) | 3,071 | |||
Cost (£’000) | 400 | Net assets (£’000) | 18,398 | |||
Valuation (£’000) | 377 | |||||
 | ||||||
Mount Engineering plc was established in April 2007 for the purpose of acquiring Mount York Limited. The acquisition of Mount York Limited marks the first step in implementing a strategy to grow the new group, both by selective acquisition and from the continual expansion of the product range. Mount Engineering has three UK subsidiaries, each well established within its industry, with a strong brand name and a recognition for quality products. The major end user market for all three subsidiaries are the oil and gas and petrochemical industries, however they also serve a range of other industrial markets including mining, waste water and pharmaceuticals. | ||||||
 |
10. Animalcare plc | Â | Â | Â | Â | Â | 68p |
Investment date | December 2007 | Â | Unaudited results for 6 months to | December 08 | ||
Equity held | 2.77% | Turnover (£’000) | 7,760 | |||
Purchase Price | 55p | Profit before tax (£’000) | 90 | |||
Cost (£’000) | 300 | Net assets (£’000) | 14,312 | |||
Valuation (£’000) | 371 | |||||
 | ||||||
Animalcare Group previously known as Ritchey, listed it shares on AIM following the acquisition of Animalcare from Genus plc by Ritchey. The enlarged group has two divisions, Animalcare and Ritchey. Ritchey is a long-established manufacturer and supplier of premium livestock products, whilst Animalcare markets and sells a range of licensed veterinary pharmaceuticals, animal identification microchips and other veterinary supplies products, with a particular focus on the companion animal sector within the UK and Ireland. It is also present in the livestock and food production animal sector. | ||||||
 |
20 May 2009
For further information please contact:
Craig McNeil
Company SecretaryCompany Secretary
Keydata AIM VCT plcKeydata AIM VCT plc
0141
228 6310
0141
228 6310